Nicotinamide and NAD-Related Pathways By reducing the methylation of nicotinamide, NNMT inhibition may leave more nicotinamide available for salvage into NAD-related pathways
Individual response varies substantially based on genetics, body composition, activity level, and dozens of other factors
NOT FOR HUMAN OR VETERINARY USE.
While definitive conclusions are premature, the assumption that unlimited B12 is harmless deserves ongoing scrutiny
By reducing nicotinamide methylation, supports cellular NAD+ availabilitya critical coenzyme for mitochondrial function, energy metabolism, and cellular repair
Response rates in the clinical trial were not 100%, and some individuals simply do not show meaningful fat mobilization from this pathway